Indexé dans
- Ouvrir la porte J
- Genamics JournalSeek
- Clés académiques
- JournalTOCs
- Infrastructure nationale des connaissances en Chine (CNKI)
- Répertoire des périodiques d'Ulrich
- RechercheRef
- Université Hamdard
- EBSCO AZ
- Répertoire d'indexation des résumés pour les revues
- OCLC - WorldCat
- Publions
- Fondation genevoise pour la formation et la recherche médicales
- Pub européen
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
Endodermal and Hepatic Differentiation from Human Embryonic Stem Cells and Human Induced Pluripotent Stem Cells
Kenji Kawabata, Kazuo Takayama, Yasuto Nagamoto, Mary S. Saldon, Maiko Higuchi and Hiroyuki Mizuguchi
Induced hepatocytes differentiated from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) have a wide range of potential applications in biomedical research, drug discovery, and the treatment of liver disease. Differentiation of human ESCs and iPSCs into endodermal and hepatic cell types has been achieved by several methods, including addition of soluble factors into culture medium, transduction of differentiation-related genes, co-cultivation with other lineage cells, and a three-dimensional culture system. Each of these methods has an advantage from various points of view, such as the degree of maturation of differentiated hepatocytes, differentiation efficiency, clinical safety, and ease of handling. Currently, it is possible to select or combine the differentiation protocols to obtain ideal hepatocytes. The aim of this review is to describe the recent progress in endodermal and hepatic differentiation protocols from human ESCs and iPSCs in order to foster the suitable choice of induced hepatocytes on clinical and industrial applications.